Massive study aims to unlock cancer secrets in african ancestry

NCT ID NCT05754658

Recruiting now Knowledge-focused Sponsor: Fox Chase Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to understand the genetic and molecular drivers of breast and prostate cancer in 1,500 people of African ancestry. Participants from nine countries will provide blood and tumor samples for genetic testing. The goal is to identify inherited mutations and other genomic changes that may explain cancer disparities and improve health equity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal why certain cancers affect people of African ancestry differently and point toward more tailored treatments.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER PROSTATE CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Fox Chase Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19111, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.